Paracetamol Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 11.06 Billion |
| Market Size (2029) | USD 13.72 Billion |
| CAGR (2024 - 2029) | 4.41 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Paracetamol Market Analysis
The Paracetamol Market size is estimated at USD 11.06 billion in 2024, and is expected to reach USD 13.72 billion by 2029, growing at a CAGR of 4.41% during the forecast period (2024-2029).
The COVID-19 pandemic had a significant impact on the market. Paracetamol, due to its widespread availability, was recommended by various healthcare authorities across the world, such as the NICE, the NHS, the CDC, and the MOHFW of the Government of India, for managing fever in adults and children with COVID-19. The COVID-19 pandemic initially created a high demand for OTC analgesics, such as paracetamol, which led to restrictions on the export of essential drugs by local authorities while maintaining sufficient stock in their country. However, the majority of paracetamol API was exported from India and China. Amid the COVID-19 situation, the governments of various authorities supported the local manufacturing of paracetamol, which strengthened the local market players and their competitiveness around the world. For instance, following the COVID-19 crisis, France planned to produce more medicines nationally, starting with paracetamol. In a joint statement, health minister Oliver Véran and junior economy minister Agnès Pannier-Runacher stated on June 18, 2020, that the government is collaborating with French pharmaceutical companies Seqens, Upsa, and Sanofi to ensure the local manufacturing of and market for paracetamol. However, post-pandemic, the increased production of paracetamol through the local market players and initiatives to encourage availability is expected to drive the market's growth over the forecast period.
There are many factors responsible for the growth of the market. The rising prevalence of conditions like headaches, flu, etc., and the increasing demand for pain management drugs are some of the major ones. Paracetamol is widely used to treat mild to moderate pains, including headaches, menstrual periods, toothaches, backaches, osteoarthritis, and cold or flu aches. Furthermore, it is an effective antipyretic used to reduce fever. The growing burden of the indicative conditions and OTC use of the products is driving the market's growth. For instance, according to the Migraine Trust, migraine is the third most common disease in the world (behind dental caries and tension-type headaches). Migraine is more prevalent than diabetes, epilepsy, and asthma combined. Similarly, according to the WHO's March 2022 update, it is estimated that oral diseases affect nearly 3.5 billion people, often leading to pain and discomfort. Furthermore, according to World Population Prospects 2022, the share of the global population aged 65 years or older is projected to rise from 10% in 2022 to 16 percent in 2050. By 2050, the number of persons aged 65 or over worldwide is projected to be more than twice the number of children under age 5 and about the same as the number of children under age 12. The market is expected to witness growth as the older population is more susceptible to osteoarthritis, toothache, and other indicative diseases.
Furthermore, paracetamol is extensively used by people suffering from high temperatures and the aches and pains associated with the flu. In tropical areas, influenza occurs throughout the year. In the Northern Hemisphere, the influenza season typically starts in early fall, peaks in mid-February, and ends in the late spring of the following year. The duration and severity of influenza epidemics vary, depending on the virus subtype involved. Also, the WHO, January 2022 update, the WHO GISRS laboratories tested more than 317,198 specimens from 27th December 2021 to 9th January 2022. There were 16,862 people who tested positive for influenza viruses, of whom 10,744 (63.7%) were typed as influenza A and 6,118 (36.3%) as influenza B.
Consequently, the market for paracetamol is anticipated to develop at a significant rate throughout the forecast period as the frequency and burden of certain diseases and disorders continue to rise. Paracetamol's overdose effects, however, could slow the market's expansion.
Paracetamol Market Trends
Cold and Cough Segment is Dominating the Paracetamol Market
Many different types of viruses can cause a common cold. The condition is generally harmless, and symptoms usually resolve within two weeks. Consumers depend on OTC cough medicines as a first response to get relief from cough symptoms. Owing to the ease of procurement, the sale of paracetamol drugs for cough, cold, and flu has increased, particularly in highly emerging markets such as India and China. Moreover, the rising population suffering from pain and fever and growing awareness also serve as primary drivers for market growth.
Moreover, the increased production of paracetamol through local market players and initiatives to encourage availability is expected to drive segment growth over the forecast period. For instance, in June 2021, SEQENS officially launched the project to build a new paracetamol production unit in partnership with Sanofi and UPSA and with the support of the France Reliance program. It also reported that the unit will have a capacity of production of 10,000 tonnes of paracetamol per year. Additionally, painkillers such as acetaminophen (paracetamol) can relieve cold-related symptoms such as headaches, earaches, and joint pain. These painkillers can also lower a fever. The approval of such drugs by the regulatory authority is also propelling the growth of the segment. For instance, in February 2020, GlaxoSmithKline received approval from the United States Food and Drug Administration for Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief.
Thus, owing to the abovementioned factors, the market segment is expected to show growth over the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall paracetamol market throughout the forecast period. The market's growth is due to factors such as the presence of key players, the high prevalence of fever, headaches, and migraines in the region, and the established healthcare infrastructure, which are some of the key factors responsible for its large share of the market. The market growth in the United States is expected to be robust during the forecast period. According to the American Migraine Foundation, January 2021 article, there are more than 4 million adults in the United States who experience chronic daily migraine, with at least 15 headache days per month. As per the statistics, the increasing patient pool and increasing disposable revenue in this country are expected to boost the market's growth in the country.
Furthermore, beneficial government initiatives for research are some of the drivers expected to increase the market growth. For instance, according to the May 2022 update from the National Institute of Health, the government of the United States spent USD 689 million in 2020 and USD 725 million in 2021 for research on chronic pain. Since paracetamol is largely used as a pain killer, increasing research on chronic pain is expected to boost the growth of the market.
Additionally, in November 2021, the US FDA accepted the NDA for Maxigesic IV by Hyloris Pharmaceuticals SA. It is a unique combination of 1000 mg paracetamol and 300mg ibuprofen solution for infusion for the treatment of postoperative pain. Such application acceptance by the regulatory authorities may lead to the entrance of new products into the market in the future.
Thus, owing to the abovementioned factors, the market is expected to show growth in the North American region.
Paracetamol Industry Overview
The paracetamol market is moderately competitive and consists of several major players. Some companies currently dominating the market are GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Genesis Biotec Inc., Mallinckrodt Pharmaceuticals, Geno Pharma, Biological E, CFL Pharma, Cipla, and Dr. Reddy's Labs.
Paracetamol Market Leaders
-
GlaxoSmithKline plc
-
Teva Pharmaceuticals USA, Inc.
-
Sanofi
-
Mallinckrodt Pharmaceuticals
-
Sun Pharmaceutical Industries Ltd.
*Disclaimer: Major Players sorted in no particular order
Paracetamol Market News
- April 2022: IOL Chemicals and Pharmaceuticals started commercial production of paracetamol with an installed capacity of 1800 MTPA and backward integration of Para Amino Phenol (PAP).
- March 2022: Paraveganio became one of the first medicinal products in the world to be registered with The Vegan Society's Vegan Trademark. The certified vegan drug contains 500mg of the proven active ingredient paracetamol.
Paracetamol Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Conditions like Headaches, Flu etc.
- 4.2.2 Increasing Demand for Pain Management Drugs
-
4.3 Market Restraints
- 4.3.1 Side Effects of Overdosage of Paracetamol
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Dosage Form
- 5.1.1 Tablet
- 5.1.2 Capsules
- 5.1.3 Others
-
5.2 By Application
- 5.2.1 Headache and Fever
- 5.2.2 Cold and Cough
- 5.2.3 Muscle Cramps
- 5.2.4 Others
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle-East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 GlaxoSmithKline plc
- 6.1.2 Mallinckrodt Pharmaceuticals
- 6.1.3 Sanofi
- 6.1.4 Sun Pharmaceuticals Industries ltd
- 6.1.5 Teva Pharmaceuticals USA Inc.
- 6.1.6 Dr. Reddy's Laboratories
- 6.1.7 Biological E Ltd
- 6.1.8 CFL Pharma
- 6.1.9 Cipla
- 6.1.10 Genesis Biotec Inc.
- 6.1.11 Granules India
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityParacetamol Industry Segmentation
As per the scope of the report, paracetamol is the most widely used analgesic and antipyretic that relieves pain and reduces fever. The paracetamol market is segmented by Dosage Form (Tablet, Capsules, Others), Application (Headache and Fever, Cold and Cough, Muscle Cramps, Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Dosage Form | Tablet | |
| Capsules | ||
| Others | ||
| By Application | Headache and Fever | |
| Cold and Cough | ||
| Muscle Cramps | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Paracetamol Market Research FAQs
How big is the Paracetamol Market?
The Paracetamol Market size is expected to reach USD 11.06 billion in 2024 and grow at a CAGR of 4.41% to reach USD 13.72 billion by 2029.
What is the current Paracetamol Market size?
In 2024, the Paracetamol Market size is expected to reach USD 11.06 billion.
Who are the key players in Paracetamol Market?
GlaxoSmithKline plc, Teva Pharmaceuticals USA, Inc., Sanofi, Mallinckrodt Pharmaceuticals and Sun Pharmaceutical Industries Ltd. are the major companies operating in the Paracetamol Market.
Which is the fastest growing region in Paracetamol Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Paracetamol Market?
In 2024, the North America accounts for the largest market share in Paracetamol Market.
What years does this Paracetamol Market cover, and what was the market size in 2023?
In 2023, the Paracetamol Market size was estimated at USD 10.57 billion. The report covers the Paracetamol Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Paracetamol Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Paracetamol Industry Report
The report covers the global paracetamol market, highlighting its share and industry trends. It is segmented by dosage form, including tablets and capsules, and by application, such as headache and fever, cold and cough, and muscle cramps. The geographical segmentation includes North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The report offers detailed value estimations for these segments.
The market size and price trend are crucial aspects of this analysis, which is available as a free report PDF download. The global market is thoroughly reviewed, focusing on market share and market value. Sales data and report PDFs are also included to provide comprehensive industry insights.
The growth rate and industry analysis are pivotal in understanding market dynamics. Industry information and industry outlook are provided, with detailed industry reports and industry research highlighting market trends. The report includes industry sales, industry size, and industry statistics, giving a holistic view of the market.
Market data and market forecast are integral parts of the report, which also delves into market growth and identifies market leaders. The market outlook and market overview offer predictions and a review of market segmentation. The report example and research companies provide additional context to the market value.
In summary, this report is an essential resource for understanding the paracetamol market, offering valuable insights into its current state and future prospects.
